1. Cytostatic drugs in infants: A review on pharmacokinetic data in infants
   Hendrik van den Berg et al, 2012, Cancer Treatment Reviews CrossRef
2. Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial
   G. Cefalo et al, 2014, Neuro-Oncology CrossRef
3. Enhancement of vinorelbine-induced cytotoxicity and apoptosis by clomipramine and lithium chloride in human neuroblastoma cancer cell line SH-SY5Y
   Ayhan Bilir et al, 2010, J Neurooncol CrossRef
4. Temozolomide and Other Potential Agents for the Treatment of Glioblastoma Multiforme
   Daniel T. Nagasawa et al, 2012, Neurosurgery Clinics of North America CrossRef
5. Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in oligodendroglial tumors
   Lu-Ting Kuo et al, 2016, Cancer Med CrossRef
6. Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours
   A O von Bueren et al, 2012, Br J Cancer CrossRef
7. Aberrant Methylation of Different DNA Repair Genes Demonstrates Distinct Prognostic Value for Esophageal Cancer
   Zhi-Qiang Ling et al, 2011, Dig Dis Sci CrossRef
8. Epigenetics and Brain Cancer
   Davide Sciuscio et al, 2013 CrossRef
9. The Epigenetics of Brain Tumors
   Adrian M. Dubuc et al, 2012 CrossRef
10. Transforming approaches to treating TRK fusion cancer: historical comparison of Larotrectinib and histology-specific therapies
    Megan Pollack et al, 2020, Current Medical Research and Opinion CrossRef
11. The Transcription Factor Evi-1 Is Overexpressed, Promotes Proliferation, and Is Prognostically Unfavorable in Infratentorial Ependymomas
    Björn Koos et al, 2011, Clin Cancer Res CrossRef
12. 10.1016/b978-1-4557-5414-4.00046-2
    Hiroto Inaba et al, 2015 CrossRef